SELLAS Life Sciences Group, Inc.: accounts_receivable
| Value | {"amount": 3683000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-12-31) |
| Status | current |
| Entity | SELLAS Life Sciences Group, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:26:25.008981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d92d582e-73da-4791-adda-c3ec2f9635f2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001390478-14-000016 · Open the official SEC filing →Retrieved: 2026-08-19T13:26:25.008981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001390478/accounts-receivable/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d92d582e-73da-4791-adda-c3ec2f9635f2
History
- no predecessors — first report